Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Technology
PATRICK SEITZ

Chip Design Firm Synopsys Delivers Higher Profits On In-Line Sales

Chip design software firm Synopsys late Wednesday topped analyst estimates for earnings on in-line sales for its fiscal first quarter. For the current quarter, it guided higher than views for both earnings and sales. SNPS stock rose in extended trading.

The Sunnyvale, Calif.-based company earned an adjusted $3.56 a share on sales of $1.65 billion in the quarter ended Jan. 31. Analysts polled by FactSet had expected earnings of $3.43 a share on sales of $1.65 billion. On a year-over-year basis, Synopsys earnings surged 36%, while sales increased 21%.

For the current quarter ending April 30, Synopsys forecast adjusted earnings of $3.12 a share on sales of $1.58 billion. That's based on the midpoint of its guidance. Wall Street was modeling earnings of $3 a share on sales of $1.56 billion in the fiscal second quarter. In the year-earlier period, Synopsys earned $2.54 a share on sales of $1.4 billion.

For the full year ending Oct. 31, Synopsys predicted adjusted earnings of $13.51 a share on sales of $6.6 billion, based on the midpoint of its outlook. Analysts had been expecting earnings of $13.46 a share on sales of $6.62 billion.

SNPS Stock Rises After Report

In after-hours trading on the stock market today, SNPS stock rose 3% to 560. During the regular session Wednesday, SNPS stock dipped 0.8% to close at 543.57.

On Feb. 5, SNPS stock broke out of a cup-with-handle base at a buy point of 554.57, according to IBD MarketSmith charts. Since then, it has bobbed and weaved in and out of the 5% buy zone. It hit a regular-session record high of 582.85 on Feb. 9.

"AI continues to drive our customers' investments in silicon and systems," Chief Executive Sassine Ghazi said in a news release.

He added, "In the face of mounting design complexity, technology R&D teams are counting on Synopsys' broad portfolio of semiconductor IP (intellectual property) and leading design solutions from silicon to systems."

Synopsys Is On 3 IBD Lists

On Jan. 16, Synopsys announced plans to acquire engineering simulation software firm Ansys for about $35 billion. The deal will combine Synopsys' semiconductor and electronic design automation technology with Ansys' simulation and analysis portfolio to create a leader in "silicon-to-systems design solutions," the companies said. The transaction is due to close in the first half of 2025.

SNPS stock is on three IBD stock lists: Big Cap 20, Long-Term Leaders and Tech Leaders.

Follow Patrick Seitz on X, formerly Twitter, at @IBD_PSeitz for more stories on consumer technology, software and semiconductor stocks.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.